DermTech Inc
NASDAQ:DMTK
DermTech Inc
Change in Working Capital
DermTech Inc
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
DermTech Inc
NASDAQ:DMTK
|
Change in Working Capital
$11k
|
CAGR 3-Years
-84%
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Working Capital
$3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
38%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Working Capital
-$2.2B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Working Capital
-$422m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Working Capital
-$275.3m
|
CAGR 3-Years
-158%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Working Capital
$105.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is DermTech Inc's Change in Working Capital?
Change in Working Capital
11k
USD
Based on the financial report for Mar 31, 2024, DermTech Inc's Change in Working Capital amounts to 11k USD.
What is DermTech Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-63%
Over the last year, the Change in Working Capital growth was -97%. The average annual Change in Working Capital growth rates for DermTech Inc have been -84% over the past three years , -63% over the past five years .